Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
117.50    0.50 (0.43%)
Bid:
115.50
Ask:
118.00
Spread: 2.50 (2.165%)
Market Cap: £259.73m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Update on Buyback Programme

31 Mar 2026 07:00

RNS Number : 7048Y
Real Estate Credit Investments Ltd
31 March 2026
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO ANY US PERSONS OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION, OR TO ANY PERSON, WHERE DOING SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

31 March 2026

 

Real Estate Credit Investments Limited

("RECI" or the "Company")

Update on Buyback Programme

 

In September 2025, the Board of Directors of the Company announced an extension to its ongoing share buyback programme to run to 31 March 2026. A total of 650,000 ordinary shares of no par value each ("Ordinary Shares") have been purchased for treasury for an aggregate amount of £0.8 million, during the period from 1 October 2025 to 30 March 2026.

 

As previously announced, the Company considers all options when deciding on the appropriate allocation of the Company's available cash resources, including implementing share buybacks and investment in attractive high yielding opportunities to enhance RECI's returns.

 

The Company's principal focus has been on new and existing investment opportunities that can deliver an attractive yield to shareholders, particularly in the context of a steadily improving discount position since the commencement of the buyback programmes. During the current buyback programme, the Ordinary Shares traded at an average discount of 12.5 per cent. versus 13.1 per cent. over the previous programme.

 

Following expiry of the Company's current buyback programme, the Company will continue to consider share buybacks on an ongoing basis, utilising the Company's shareholder authority to purchase up to 33,231,931 ordinary shares granted at the Company's annual general meeting ("AGM") on 17 September 2025 (with a similar shareholder resolution expected to be tabled at the Company's next AGM).

 

The decision on whether to complete buybacks will be determined by available investment opportunities, the prevailing share price discount, available cash resources and considering prevailing market conditions. In periods of market volatility (such as we are currently experiencing), the Company will balance potential share buybacks versus maintaining appropriate levels of cash reserves. The Company will provide further updates on the progression of the buyback approach as part of its half-year and annual reports.

 

To complete the share buybacks, the Company will appoint Panmure Liberum to make market purchases of Ordinary Shares in on its behalf. Panmure Liberum will purchase the Ordinary Shares as principal (and not as agent) and sell them on to the Company. The Company intends that any Ordinary Shares purchased by the Company will be held in treasury.

 

Any share purchases will be made in accordance with certain pre-set parameters set out in the terms of Panmure Liberum's engagement, the general authority of the Company to repurchase shares granted by shareholders at the Company's 2025 annual general meeting; and the EU Market Abuse Regulation (596/2014) as it forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended); and Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

 

The maximum price payable per share (exclusive of expenses) must not exceed the higher of: (i) 105 per cent. of the average middle market quotations for the five business days preceding the date of purchase; and (ii) the higher of the last independent trade and the highest current independent bid on the London Stock Exchange.

 

A buy-back of Ordinary Shares on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the Exchange (and could exceed the 25 per cent. limit of the average daily trading volume of the preceding 20 business days as referred to in the Commission Delegated Regulation (EU) No. 2016/1052 on buy-back programmes (as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018)).

 

Any purchase of Ordinary Shares by the Company will be notified through an RIS announcement in accordance with the UK Listing Rules. Shareholders should note that whether a buyback of Ordinary Shares is made is based on a number of factors and, accordingly, no expectation or reliance should be placed on Panmure Liberum exercising such discretion on any one or more occasions.

 

 

 

 

Enquiries:

Cheyne Capital Management (UK) LLP (Investment Manager)

+44 (0) 20 7968 7450

RECIIR@cheynecapital.com

 

 

 

Panmure Liberum (Corporate Broker)

+44 (0) 20 3100 2222

Darren Vickers/Alex Collins

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRGDXIBXDGLG
Date   Source Headline
20th Mar 20251:32 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNSFact Sheet Announcement
14th Mar 20254:34 pmRNSDirector/PDMR Shareholding
19th Feb 20252:59 pmRNSDividend Declaration
14th Feb 20257:00 amRNSFact Sheet Announcement
22nd Jan 20257:00 amRNSFact Sheet Announcement
20th Dec 20242:06 pmRNSDirector/PDMR Shareholding
17th Dec 20243:13 pmRNSFact Sheet Announcement
28th Nov 20243:04 pmRNSDirector/PDMR Shareholding
28th Nov 20247:00 amRNSDividend Declaration
28th Nov 20247:00 amRNSHalf-year Report
12th Nov 20247:00 amRNSFact Sheet Announcement
5th Nov 20247:00 amRNSDirector Appointment
28th Oct 20247:00 amRNSShare Buyback Programme in a Closed Period
15th Oct 20247:00 amRNSFact Sheet Announcement
10th Oct 20242:25 pmRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSFact Sheet Announcement
30th Sep 20243:30 pmRNSBoard Succession Update
27th Sep 20247:00 amRNSFurther Buyback Programme
25th Sep 20244:43 pmRNSHolding(s) in Company
18th Sep 20244:30 pmRNSDividend Declaration
18th Sep 20243:59 pmRNSResult of AGM and Directorate Change
10th Sep 20247:01 amRNSFact Sheet Announcement
10th Sep 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20244:56 pmRNSHolding(s) in Company
16th Aug 20245:10 pmRNSHolding(s) in Company
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20249:11 amRNSHolding(s) in Company
13th Aug 20247:00 amRNSFact Sheet Announcement
12th Aug 20247:00 amRNSNotice of AGM
9th Aug 20243:00 pmRNSHolding(s) in Company
5th Aug 20245:00 pmRNSHolding(s) in Company
16th Jul 20242:11 pmRNSNew Transaction
9th Jul 20247:00 amRNSFact Sheet Announcement
20th Jun 20247:00 amRNSDividend Declaration
20th Jun 20247:00 amRNSAnnual Financial Report
18th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 202412:30 pmRNSBoard Changes
11th Jun 20245:08 pmRNSHolding(s) in Company
10th Jun 20247:00 amRNSFact Sheet Announcement
28th May 20249:19 amRNSDirector Declaration
21st May 20244:00 pmRNSShare Buyback Programme in a Closed Period
15th May 20244:06 pmRNSHolding(s) in Company
13th May 20247:00 amRNSFact Sheet Announcement
8th May 20247:00 amRNSDirector Appointment
2nd May 20247:00 amRNSNotice of RECI Investor Day
25th Apr 20242:30 pmRNSHolding(s) in Company
16th Apr 202411:56 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSFact Sheet Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.